types of glp 1 drugs List approved and pending GLP-1 medications How does Ozempic work? The

Saxenda (active ingredient: liraglutide) subcutaneous injection Initial FDA Approval: 2014 (liraglutide approved in 2010) Side Effect Update Date: May 28, 2025 Medication Description: For chronic weight management Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting

[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Yusuf Z.I., Dongarwar D., Yusuf R.A., Bell M., Harris T., Salihu H.M

Which is right for me

The medication arrives in packaging that is damaged, open, labeled in a foreign language or has no expiration date

Tsoukas, Yu, and Peters provided clinical expertise and critically revised the manuscript for important intellectual content

All other authors declare no COI